Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

New MD takes over at Lloyds and AAH

Business Cormac Tobin, who has been MD of Celesio’s Irish retail arm Unicarepharmacy since 2006, has replaced Mark James (pictured) who left the company last week.

The UK boss of Lloydspharmacy and AAH has been replaced by the managing director of the parent company's Irish division.


Cormac Tobin, who has been MD of Celesio's Irish retail arm Unicarepharmacy since 2006, has replaced Mark James (pictured, right) who left the company last week.


Mr James, who was appointed group managing director of AAH Pharmaceuticals in January 2008, had been MD of both AAH and Lloydspharmacy since early last year. A spokesperson for Celesio said they were unable to provide further details of Mr James' departure at present.


Mr James had been with Celesio for more than 15 years in various senior positions.


What are the big challenges Lloyds' new MD needs to tackle first?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016034

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel